Skip to main content
Top
Published in: Diabetologia 6/2012

01-06-2012 | Article

Aberrant activation of liver X receptors impairs pancreatic beta cell function through upregulation of sterol regulatory element-binding protein 1c in mouse islets and rodent cell lines

Authors: Z. X. Meng, Y. Yin, J. H. Lv, M. Sha, Y. Lin, L. Gao, Y. X. Zhu, Y. J. Sun, X. Han

Published in: Diabetologia | Issue 6/2012

Login to get access

Abstract

Aims/hypothesis

Liver X receptors (LXR) are important transcriptional regulators of lipid and glucose metabolism. Our previous report demonstrated that LXR activation inhibited pancreatic beta cell proliferation through cell cycle arrest. Here we explore the role of LXR activation in beta cell insulin secretion and the underlying mechanism that might be involved.

Methods

Mouse pancreatic islets or insulin-secreting MIN6 cells were exposed to the LXR agonist, T0901317, and insulin secretion, glucose and fatty acid oxidation, and lipogenic gene expression were assessed. The unsaturated fatty acid eicosapentaenoic acid and the dominant negative sterol regulatory element binding protein 1c (SREBP1c) were used to inhibit endogenous SREBP1c and evaluate the involvement of SREBP1c in beta cell dysfunction induced by LXR activation.

Results

Treatment with the LXR agonist decreased beta cell glucose sensitivity and impaired glucose-stimulated insulin secretion in vivo and in vitro. This was accompanied by derangements of beta cell glucose oxygen consumption, glucose oxidation, ATP production and intracellular voltage-gated calcium channel flux. LXR activation also regulated the expression of lipid metabolism-related genes such as Fas, Acc (also known as Acaca) and Cpt1a, and led to intracellular lipid accumulation. Further studies revealed that inhibition of SREBP1c abolished LXR activation-induced lipid accumulation and improved beta cell glucose metabolism, ATP production and insulin secretion.

Conclusions/interpretation

Our data reveal that aberrant activation of LXR reproduced the phenomenon of beta cell dysfunction in the development of type 2 diabetes in vitro and in vivo. Upregulation of SREBP1c production and the lipotoxicity mediated by it played a central role in this process.
Appendix
Available only for authorised users
Literature
1.
go back to reference Saltiel AR (2001) New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell 104:517–529PubMedCrossRef Saltiel AR (2001) New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell 104:517–529PubMedCrossRef
2.
go back to reference Del Guerra S, Lupi R, Marselli L et al (2005) Functional and molecular defects of pancreatic islets in human type 2 diabetes. Diabetes 54:727–735PubMedCrossRef Del Guerra S, Lupi R, Marselli L et al (2005) Functional and molecular defects of pancreatic islets in human type 2 diabetes. Diabetes 54:727–735PubMedCrossRef
3.
go back to reference Poitout V, Robertson RP (2008) Glucolipotoxicity: fuel excess and beta-cell dysfunction. Endocr Rev 29:351–366PubMedCrossRef Poitout V, Robertson RP (2008) Glucolipotoxicity: fuel excess and beta-cell dysfunction. Endocr Rev 29:351–366PubMedCrossRef
4.
go back to reference Prentki M, Nolan CJ (2006) Islet beta cell failure in type 2 diabetes. J Clin Invest 116:1802–1812PubMedCrossRef Prentki M, Nolan CJ (2006) Islet beta cell failure in type 2 diabetes. J Clin Invest 116:1802–1812PubMedCrossRef
5.
go back to reference Henquin JC (2000) Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 49:1751–1760PubMedCrossRef Henquin JC (2000) Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 49:1751–1760PubMedCrossRef
6.
go back to reference Nenquin M, Szollosi A, Aguilar-Bryan L, Bryan J, Henquin JC (2004) Both triggering and amplifying pathways contribute to fuel-induced insulin secretion in the absence of sulfonylurea receptor-1 in pancreatic beta-cells. J Biol Chem 279:32316–32324PubMedCrossRef Nenquin M, Szollosi A, Aguilar-Bryan L, Bryan J, Henquin JC (2004) Both triggering and amplifying pathways contribute to fuel-induced insulin secretion in the absence of sulfonylurea receptor-1 in pancreatic beta-cells. J Biol Chem 279:32316–32324PubMedCrossRef
7.
go back to reference Bernal-Mizrachi E, Fatrai S, Johnson JD et al (2004) Defective insulin secretion and increased susceptibility to experimental diabetes are induced by reduced Akt activity in pancreatic islet beta cells. J Clin Invest 114:928–936PubMed Bernal-Mizrachi E, Fatrai S, Johnson JD et al (2004) Defective insulin secretion and increased susceptibility to experimental diabetes are induced by reduced Akt activity in pancreatic islet beta cells. J Clin Invest 114:928–936PubMed
8.
go back to reference Brunham LR, Kruit JK, Verchere CB, Hayden MR (2008) Cholesterol in islet dysfunction and type 2 diabetes. J Clin Invest 118:403–408PubMedCrossRef Brunham LR, Kruit JK, Verchere CB, Hayden MR (2008) Cholesterol in islet dysfunction and type 2 diabetes. J Clin Invest 118:403–408PubMedCrossRef
10.
go back to reference Steffensen KR, Gustafsson JA (2004) Putative metabolic effects of the liver X receptor (LXR). Diabetes 53(Suppl 1):S36–S42PubMedCrossRef Steffensen KR, Gustafsson JA (2004) Putative metabolic effects of the liver X receptor (LXR). Diabetes 53(Suppl 1):S36–S42PubMedCrossRef
11.
go back to reference Korach-Andre M, Archer A, Barros RP, Parini P, Gustafsson JA (2011) Both liver-X receptor (LXR) isoforms control energy expenditure by regulating brown adipose tissue activity. Proc Natl Acad Sci USA 108:403–408PubMedCrossRef Korach-Andre M, Archer A, Barros RP, Parini P, Gustafsson JA (2011) Both liver-X receptor (LXR) isoforms control energy expenditure by regulating brown adipose tissue activity. Proc Natl Acad Sci USA 108:403–408PubMedCrossRef
12.
go back to reference Gerin I, Dolinsky VW, Shackman JG et al (2005) LXRbeta is required for adipocyte growth, glucose homeostasis, and beta cell function. J Biol Chem 280:23024–23031PubMedCrossRef Gerin I, Dolinsky VW, Shackman JG et al (2005) LXRbeta is required for adipocyte growth, glucose homeostasis, and beta cell function. J Biol Chem 280:23024–23031PubMedCrossRef
13.
go back to reference Meng ZX, Nie J, Ling JJ et al (2009) Activation of liver X receptors inhibits pancreatic islet beta cell proliferation through cell cycle arrest. Diabetologia 52:125–135PubMedCrossRef Meng ZX, Nie J, Ling JJ et al (2009) Activation of liver X receptors inhibits pancreatic islet beta cell proliferation through cell cycle arrest. Diabetologia 52:125–135PubMedCrossRef
14.
go back to reference Choe SS, Choi AH, Lee JW et al (2007) Chronic activation of liver X receptor induces beta-cell apoptosis through hyperactivation of lipogenesis: liver X receptor-mediated lipotoxicity in pancreatic beta-cells. Diabetes 56:1534–1543PubMedCrossRef Choe SS, Choi AH, Lee JW et al (2007) Chronic activation of liver X receptor induces beta-cell apoptosis through hyperactivation of lipogenesis: liver X receptor-mediated lipotoxicity in pancreatic beta-cells. Diabetes 56:1534–1543PubMedCrossRef
15.
go back to reference Murakami H, Tamasawa N, Matsui J, Yasujima M, Suda T (2000) Plasma oxysterols and tocopherol in patients with diabetes mellitus and hyperlipidemia. Lipids 35:333–338PubMedCrossRef Murakami H, Tamasawa N, Matsui J, Yasujima M, Suda T (2000) Plasma oxysterols and tocopherol in patients with diabetes mellitus and hyperlipidemia. Lipids 35:333–338PubMedCrossRef
16.
go back to reference Ferderbar S, Pereira EC, Apolinario E et al (2007) Cholesterol oxides as biomarkers of oxidative stress in type 1 and type 2 diabetes mellitus. Diabetes Metab Res Rev 23:35–42PubMedCrossRef Ferderbar S, Pereira EC, Apolinario E et al (2007) Cholesterol oxides as biomarkers of oxidative stress in type 1 and type 2 diabetes mellitus. Diabetes Metab Res Rev 23:35–42PubMedCrossRef
17.
go back to reference Mitro N, Mak PA, Vargas L et al (2007) The nuclear receptor LXR is a glucose sensor. Nature 445:219–223PubMedCrossRef Mitro N, Mak PA, Vargas L et al (2007) The nuclear receptor LXR is a glucose sensor. Nature 445:219–223PubMedCrossRef
19.
go back to reference Cao G, Liang Y, Jiang XC, Eacho PI (2004) Liver X receptors as potential therapeutic targets for multiple diseases. Drug News Perspect 17:35–41PubMedCrossRef Cao G, Liang Y, Jiang XC, Eacho PI (2004) Liver X receptors as potential therapeutic targets for multiple diseases. Drug News Perspect 17:35–41PubMedCrossRef
20.
go back to reference Bruemmer D, Law RE (2005) Liver x receptors: potential novel targets in cardiovascular diseases. Curr Drug Targets Cardiovasc Haematol Disord 5:533–540PubMedCrossRef Bruemmer D, Law RE (2005) Liver x receptors: potential novel targets in cardiovascular diseases. Curr Drug Targets Cardiovasc Haematol Disord 5:533–540PubMedCrossRef
21.
go back to reference Kakuma T, Lee Y, Higa M et al (2000) Leptin, troglitazone, and the expression of sterol regulatory element binding proteins in liver and pancreatic islets. Proc Natl Acad Sci USA 97:8536–8541PubMedCrossRef Kakuma T, Lee Y, Higa M et al (2000) Leptin, troglitazone, and the expression of sterol regulatory element binding proteins in liver and pancreatic islets. Proc Natl Acad Sci USA 97:8536–8541PubMedCrossRef
22.
go back to reference Hansmannel F, Mordier S, Iynedjian PB (2006) Insulin induction of glucokinase and fatty acid synthase in hepatocytes: analysis of the roles of sterol-regulatory-element-binding protein-1c and liver X receptor. Biochem J 399:275–283PubMedCrossRef Hansmannel F, Mordier S, Iynedjian PB (2006) Insulin induction of glucokinase and fatty acid synthase in hepatocytes: analysis of the roles of sterol-regulatory-element-binding protein-1c and liver X receptor. Biochem J 399:275–283PubMedCrossRef
23.
go back to reference Talukdar S, Hillgartner FB (2006) The mechanism mediating the activation of acetyl-coenzyme A carboxylase-alpha gene transcription by the liver X receptor agonist T0-901317. J Lipid Res 47:2451–2461PubMedCrossRef Talukdar S, Hillgartner FB (2006) The mechanism mediating the activation of acetyl-coenzyme A carboxylase-alpha gene transcription by the liver X receptor agonist T0-901317. J Lipid Res 47:2451–2461PubMedCrossRef
24.
go back to reference Takahashi A, Motomura K, Kato T et al (2005) Transgenic mice overexpressing nuclear SREBP-1c in pancreatic beta-cells. Diabetes 54:492–499PubMedCrossRef Takahashi A, Motomura K, Kato T et al (2005) Transgenic mice overexpressing nuclear SREBP-1c in pancreatic beta-cells. Diabetes 54:492–499PubMedCrossRef
25.
go back to reference Diraison F, Parton L, Ferre P et al (2004) Over-expression of sterol-regulatory-element-binding protein-1c (SREBP1c) in rat pancreatic islets induces lipogenesis and decreases glucose-stimulated insulin release: modulation by 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR). Biochem J 378:769–778PubMedCrossRef Diraison F, Parton L, Ferre P et al (2004) Over-expression of sterol-regulatory-element-binding protein-1c (SREBP1c) in rat pancreatic islets induces lipogenesis and decreases glucose-stimulated insulin release: modulation by 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR). Biochem J 378:769–778PubMedCrossRef
26.
27.
go back to reference Felder TK, Oberkofler H, Weitgasser R et al (2007) The SREBF-1 locus is associated with type 2 diabetes and plasma adiponectin levels in a middle-aged Austrian population. Int J Obes (Lond) 31:1099–1103CrossRef Felder TK, Oberkofler H, Weitgasser R et al (2007) The SREBF-1 locus is associated with type 2 diabetes and plasma adiponectin levels in a middle-aged Austrian population. Int J Obes (Lond) 31:1099–1103CrossRef
28.
go back to reference Shimano H, Amemiya-Kudo M, Takahashi A, Kato T, Ishikawa M, Yamada N (2007) Sterol regulatory element-binding protein-1c and pancreatic beta-cell dysfunction. Diabetes Obes Metab 9(Suppl 2):133–139PubMedCrossRef Shimano H, Amemiya-Kudo M, Takahashi A, Kato T, Ishikawa M, Yamada N (2007) Sterol regulatory element-binding protein-1c and pancreatic beta-cell dysfunction. Diabetes Obes Metab 9(Suppl 2):133–139PubMedCrossRef
29.
go back to reference Faulds MH, Zhao C, Dahlman-Wright K (2010) Molecular biology and functional genomics of liver X receptors (LXR) in relationship to metabolic diseases. Curr Opin Pharmacol 10:692–697PubMedCrossRef Faulds MH, Zhao C, Dahlman-Wright K (2010) Molecular biology and functional genomics of liver X receptors (LXR) in relationship to metabolic diseases. Curr Opin Pharmacol 10:692–697PubMedCrossRef
30.
go back to reference Ogihara T, Chuang JC, Vestermark GL et al (2010) Liver X receptor agonists augment human islet function through activation of anaplerotic pathways and glycerolipid/free fatty acid cycling. J Biol Chem 285:5392–5404PubMedCrossRef Ogihara T, Chuang JC, Vestermark GL et al (2010) Liver X receptor agonists augment human islet function through activation of anaplerotic pathways and glycerolipid/free fatty acid cycling. J Biol Chem 285:5392–5404PubMedCrossRef
31.
go back to reference Wente W, Brenner MB, Zitzer H, Gromada J, Efanov AM (2007) Activation of liver X receptors and retinoid X receptors induces growth arrest and apoptosis in insulin-secreting cells. Endocrinology 148:1843–1849PubMedCrossRef Wente W, Brenner MB, Zitzer H, Gromada J, Efanov AM (2007) Activation of liver X receptors and retinoid X receptors induces growth arrest and apoptosis in insulin-secreting cells. Endocrinology 148:1843–1849PubMedCrossRef
32.
go back to reference Miyazaki J, Araki K, Yamato E et al (1990) Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms. Endocrinology 127:126–132PubMedCrossRef Miyazaki J, Araki K, Yamato E et al (1990) Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms. Endocrinology 127:126–132PubMedCrossRef
33.
go back to reference Santerre RF, Cook RA, Crisel RM et al (1981) Insulin synthesis in a clonal cell line of simian virus 40-transformed hamster pancreatic beta cells. Proc Natl Acad Sci USA 78:4339–4343PubMedCrossRef Santerre RF, Cook RA, Crisel RM et al (1981) Insulin synthesis in a clonal cell line of simian virus 40-transformed hamster pancreatic beta cells. Proc Natl Acad Sci USA 78:4339–4343PubMedCrossRef
34.
go back to reference Meng ZX, Sun JX, Ling JJ et al (2006) Prostaglandin E2 regulates Foxo activity via the Akt pathway: implications for pancreatic islet beta cell dysfunction. Diabetologia 49:2959–2968PubMedCrossRef Meng ZX, Sun JX, Ling JJ et al (2006) Prostaglandin E2 regulates Foxo activity via the Akt pathway: implications for pancreatic islet beta cell dysfunction. Diabetologia 49:2959–2968PubMedCrossRef
35.
go back to reference He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B (1998) A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 95:2509–2514PubMedCrossRef He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B (1998) A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 95:2509–2514PubMedCrossRef
36.
go back to reference Sakurai K, Cederbaum AI (1998) Oxidative stress and cytotoxicity induced by ferric-nitrilotriacetate in HepG2 cells that express cytochrome P450 2E1. Mol Pharmacol 54:1024–1035PubMed Sakurai K, Cederbaum AI (1998) Oxidative stress and cytotoxicity induced by ferric-nitrilotriacetate in HepG2 cells that express cytochrome P450 2E1. Mol Pharmacol 54:1024–1035PubMed
37.
go back to reference Lawrence CL, Proks P, Rodrigo GC et al (2001) Gliclazide produces high-affinity block of KATP channels in mouse isolated pancreatic beta cells but not rat heart or arterial smooth muscle cells. Diabetologia 44:1019–1025PubMedCrossRef Lawrence CL, Proks P, Rodrigo GC et al (2001) Gliclazide produces high-affinity block of KATP channels in mouse isolated pancreatic beta cells but not rat heart or arterial smooth muscle cells. Diabetologia 44:1019–1025PubMedCrossRef
38.
go back to reference Piaggi S, Novelli M, Martino L et al (2007) Cell death and impairment of glucose-stimulated insulin secretion induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the beta-cell line INS-1E. Toxicol Appl Pharmacol 220:333–340PubMedCrossRef Piaggi S, Novelli M, Martino L et al (2007) Cell death and impairment of glucose-stimulated insulin secretion induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the beta-cell line INS-1E. Toxicol Appl Pharmacol 220:333–340PubMedCrossRef
39.
go back to reference Assimacopoulos-Jeannet F, Thumelin S, Roche E, Esser V, McGarry JD, Prentki M (1997) Fatty acids rapidly induce the carnitine palmitoyltransferase I gene in the pancreatic beta-cell line INS-1. J Biol Chem 272:1659–1664PubMedCrossRef Assimacopoulos-Jeannet F, Thumelin S, Roche E, Esser V, McGarry JD, Prentki M (1997) Fatty acids rapidly induce the carnitine palmitoyltransferase I gene in the pancreatic beta-cell line INS-1. J Biol Chem 272:1659–1664PubMedCrossRef
40.
go back to reference Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911–917PubMedCrossRef Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911–917PubMedCrossRef
41.
go back to reference Chisholm JW, Hong J, Mills SA, Lawn RM (2003) The LXR ligand T0901317 induces severe lipogenesis in the db/db diabetic mouse. J Lipid Res 44:2039–2048PubMedCrossRef Chisholm JW, Hong J, Mills SA, Lawn RM (2003) The LXR ligand T0901317 induces severe lipogenesis in the db/db diabetic mouse. J Lipid Res 44:2039–2048PubMedCrossRef
42.
go back to reference Davies JD, Carpenter KL, Challis IR et al (2005) Adipocytic differentiation and liver x receptor pathways regulate the accumulation of triacylglycerols in human vascular smooth muscle cells. J Biol Chem 280:3911–3919PubMedCrossRef Davies JD, Carpenter KL, Challis IR et al (2005) Adipocytic differentiation and liver x receptor pathways regulate the accumulation of triacylglycerols in human vascular smooth muscle cells. J Biol Chem 280:3911–3919PubMedCrossRef
43.
go back to reference Seo JB, Moon HM, Kim WS et al (2004) Activated liver X receptors stimulate adipocyte differentiation through induction of peroxisome proliferator-activated receptor gamma expression. Mol Cell Biol 24:3430–3444PubMedCrossRef Seo JB, Moon HM, Kim WS et al (2004) Activated liver X receptors stimulate adipocyte differentiation through induction of peroxisome proliferator-activated receptor gamma expression. Mol Cell Biol 24:3430–3444PubMedCrossRef
44.
go back to reference Zitzer H, Wente W, Brenner MB et al (2006) Sterol regulatory element-binding protein 1 mediates liver X receptor-beta-induced increases in insulin secretion and insulin messenger ribonucleic acid levels. Endocrinology 147:3898–3905PubMedCrossRef Zitzer H, Wente W, Brenner MB et al (2006) Sterol regulatory element-binding protein 1 mediates liver X receptor-beta-induced increases in insulin secretion and insulin messenger ribonucleic acid levels. Endocrinology 147:3898–3905PubMedCrossRef
45.
go back to reference Efanov AM, Sewing S, Bokvist K, Gromada J (2004) Liver X receptor activation stimulates insulin secretion via modulation of glucose and lipid metabolism in pancreatic beta-cells. Diabetes 53(Suppl 3):S75–S78PubMedCrossRef Efanov AM, Sewing S, Bokvist K, Gromada J (2004) Liver X receptor activation stimulates insulin secretion via modulation of glucose and lipid metabolism in pancreatic beta-cells. Diabetes 53(Suppl 3):S75–S78PubMedCrossRef
46.
go back to reference Choi SE, Jung IR, Lee YJ et al (2011) Stimulation of lipogenesis as well as fatty acid oxidation protects against palmitate-induced INS-1 beta-cell death. Endocrinology 152:816–827PubMedCrossRef Choi SE, Jung IR, Lee YJ et al (2011) Stimulation of lipogenesis as well as fatty acid oxidation protects against palmitate-induced INS-1 beta-cell death. Endocrinology 152:816–827PubMedCrossRef
47.
go back to reference Hellemans KH, Hannaert JC, Denys B et al (2009) Susceptibility of pancreatic beta cells to fatty acids is regulated by LXR/PPARalpha-dependent stearoyl-coenzyme A desaturase. PLoS One 4:e7266PubMedCrossRef Hellemans KH, Hannaert JC, Denys B et al (2009) Susceptibility of pancreatic beta cells to fatty acids is regulated by LXR/PPARalpha-dependent stearoyl-coenzyme A desaturase. PLoS One 4:e7266PubMedCrossRef
48.
go back to reference Green CD, Jump DB, Olson LK (2009) Elevated insulin secretion from liver X receptor-activated pancreatic beta-cells involves increased de novo lipid synthesis and triacylglyceride turnover. Endocrinology 150:2637–2645PubMedCrossRef Green CD, Jump DB, Olson LK (2009) Elevated insulin secretion from liver X receptor-activated pancreatic beta-cells involves increased de novo lipid synthesis and triacylglyceride turnover. Endocrinology 150:2637–2645PubMedCrossRef
Metadata
Title
Aberrant activation of liver X receptors impairs pancreatic beta cell function through upregulation of sterol regulatory element-binding protein 1c in mouse islets and rodent cell lines
Authors
Z. X. Meng
Y. Yin
J. H. Lv
M. Sha
Y. Lin
L. Gao
Y. X. Zhu
Y. J. Sun
X. Han
Publication date
01-06-2012
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 6/2012
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-012-2516-2

Other articles of this Issue 6/2012

Diabetologia 6/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.